![](/img/cover-not-exists.png)
Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II Trial
Petrylak, D. P., Tagawa, S. T., Kohli, M., Eisen, A., Canil, C., Sridhar, S. S., Spira, A., Yu, E. Y., Burke, J. M., Shaffer, D., Pan, C.-X., Kim, J. J., Aragon-Ching, J. B., Quinn, D. I., Vogelzang,Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2015.65.0218
Date:
February, 2016
File:
PDF, 2.16 MB
english, 2016